Lv1
20 积分 2024-09-10 加入
Sirolimus for Secondary Prevention of Cutaneous Squamous Cell Carcinoma in Kidney Transplant Recipients: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
12天前
已完结
PLOD2 Promotes Cutaneous Squamous Cell Carcinoma Progression in Association With STAT3‐Related ERK and AKT Pathways
12天前
已完结
Targeting the PI3K pathway in cancer: are we making headway?
12天前
已完结
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer
14天前
已完结
Road to ABT‐869: A Multitargeted Receptor Tyrosine Kinase Inhibitor
14天前
已完结
Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma
17天前
已完结
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma
17天前
已完结
LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways
18天前
已完结
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial
19天前
已完结
Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway
3个月前
已完结
皖公网安备34019202002308
